Connecticut Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Connecticut Wealth Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$3.71K	–	260
2022 Q4	$3.71K	Hold	1,000	–	–	﹤0.01%	204
2022 Q3	$5K	Hold	1,000	–	–	﹤0.01%	190
2022 Q2	$6K	Hold	1,000	–	–	﹤0.01%	187
2022 Q1	$7K	Buy	+1,000	New	+$9.8K	﹤0.01%	189

Other funds holding ORTX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Connecticut Wealth Management's ORTX Position: Q1 2023 in Review

Connecticut Wealth Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 1,000 shares — an estimated $3.71K sold.

Connecticut Wealth Management first reported a position in ORTX in Q1 2022 and held it in 4 quarters. The position peaked at $7K in Q1 2022. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

Connecticut Wealth Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Connecticut Wealth Management sold 1,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $3.71K.
Connecticut Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2022 and held it in 4 quarters.
Connecticut Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $7K in Q1 2022.
35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on Connecticut Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.